Literature DB >> 21464092

Cutting edge: NKG2D-dependent cytotoxicity is controlled by ligand distribution in the target cell membrane.

Emily Martinez1, Joseph A Brzostowski, Eric O Long, Catharina C Gross.   

Abstract

Although the importance of membrane microdomains in receptor-mediated activation of lymphocytes has been established, much less is known about the role of receptor ligand distribution on APC and target cells. Detergent-resistant membrane domains, into which GPI-linked proteins partition, are enriched in cholesterol and glycosphingolipids. ULBP1 is a GPI-linked ligand for natural cytotoxicity receptor NKG2D. To investigate how ULBP1 distribution on target cells affects NKG2D-dependent NK cell activation, we fused the extracellular domain of ULBP1 to the transmembrane domain of CD45. Introduction of this transmembrane domain eliminated the association of ULBP1 with the detergent-resistant membrane fraction and caused a significant reduction of cytotoxicity and degranulation by NK cells. Clustering and lateral diffusion of ULBP1 was not affected by changes in the membrane anchor. These results show that the partitioning of receptor ligands in discrete membrane domains of target cells is an important determinant of NK cell activation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21464092      PMCID: PMC3865715          DOI: 10.4049/jimmunol.1002254

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

Review 1.  Swapping molecules during cell-cell interactions.

Authors:  Jonathan Sprent
Journal:  Sci STKE       Date:  2005-03-01

Review 2.  Paradigm shift of the plasma membrane concept from the two-dimensional continuum fluid to the partitioned fluid: high-speed single-molecule tracking of membrane molecules.

Authors:  Akihiro Kusumi; Chieko Nakada; Ken Ritchie; Kotono Murase; Kenichi Suzuki; Hideji Murakoshi; Rinshi S Kasai; Junko Kondo; Takahiro Fujiwara
Journal:  Annu Rev Biophys Biomol Struct       Date:  2005

3.  CD80 cytoplasmic domain controls localization of CD28, CTLA-4, and protein kinase Ctheta in the immunological synapse.

Authors:  Su-Yi Tseng; Mengling Liu; Michael L Dustin
Journal:  J Immunol       Date:  2005-12-15       Impact factor: 5.422

Review 4.  Plasma membrane segregation during T cell activation: probing the order of domains.

Authors:  Thomas Harder; Carles Rentero; Tobias Zech; Katharina Gaus
Journal:  Curr Opin Immunol       Date:  2007-07-12       Impact factor: 7.486

5.  ICAM-2 redistributed by ezrin as a target for killer cells.

Authors:  T S Helander; O Carpén; O Turunen; P E Kovanen; A Vaheri; T Timonen
Journal:  Nature       Date:  1996-07-18       Impact factor: 49.962

Review 6.  Control of immune responses by trafficking cell surface proteins, vesicles and lipid rafts to and from the immunological synapse.

Authors:  Sabrina B Taner; Björn Onfelt; Niina J Pirinen; Fiona E McCann; Anthony I Magee; Daniel M Davis
Journal:  Traffic       Date:  2004-09       Impact factor: 6.215

7.  Isolation of lipid rafts from B lymphocytes.

Authors:  Anu Cherukuri; Shiang-Jong Tzeng; Arun Gidwani; Hae Won Sohn; Pavel Tolar; Michelle D Snyder; Susan K Pierce
Journal:  Methods Mol Biol       Date:  2004

Review 8.  Intercellular transfer of cell-surface proteins is common and can affect many stages of an immune response.

Authors:  Daniel M Davis
Journal:  Nat Rev Immunol       Date:  2007-02-09       Impact factor: 53.106

9.  Single-molecule microscopy reveals plasma membrane microdomains created by protein-protein networks that exclude or trap signaling molecules in T cells.

Authors:  Adam D Douglass; Ronald D Vale
Journal:  Cell       Date:  2005-06-17       Impact factor: 41.582

10.  Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells.

Authors:  Yenan T Bryceson; Michael E March; Domingo F Barber; Hans-Gustaf Ljunggren; Eric O Long
Journal:  J Exp Med       Date:  2005-10-03       Impact factor: 14.307

View more
  7 in total

1.  Impaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulation.

Authors:  Catharina C Gross; Andreas Schulte-Mecklenbeck; Anna Rünzi; Tanja Kuhlmann; Anita Posevitz-Fejfár; Nicholas Schwab; Tilman Schneider-Hohendorf; Sebastian Herich; Kathrin Held; Matea Konjević; Marvin Hartwig; Klaus Dornmair; Reinhard Hohlfeld; Tjalf Ziemssen; Luisa Klotz; Sven G Meuth; Heinz Wiendl
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-09       Impact factor: 11.205

Review 2.  NK cells: immune cross-talk and therapeutic implications.

Authors:  Anshu Malhotra; Anil Shanker
Journal:  Immunotherapy       Date:  2011-10       Impact factor: 4.196

3.  Palmitoylation of MICA, a ligand for NKG2D, mediates its recruitment to membrane microdomains and promotes its shedding.

Authors:  Sonia Agüera-González; Catharina C Gross; Lola Fernández-Messina; Omodele Ashiru; Gloria Esteso; Howard C Hang; Hugh T Reyburn; Eric O Long; Mar Valés-Gómez
Journal:  Eur J Immunol       Date:  2011-11-03       Impact factor: 5.532

4.  Human NKG2D-ligands: cell biology strategies to ensure immune recognition.

Authors:  Lola Fernández-Messina; Hugh T Reyburn; Mar Valés-Gómez
Journal:  Front Immunol       Date:  2012-09-25       Impact factor: 7.561

5.  The Glycophosphatidylinositol Anchor of the MCMV Evasin, m157, Facilitates Optimal Cell Surface Expression and Ly49 Receptor Recognition.

Authors:  Lindsey E Carlin; Natalya V Guseva; Michael R Shey; Zuhair K Ballas; Jonathan W Heusel
Journal:  PLoS One       Date:  2013-06-19       Impact factor: 3.240

6.  Stepwise phosphorylation of p65 promotes NF-κB activation and NK cell responses during target cell recognition.

Authors:  Hyung-Joon Kwon; Go-Eun Choi; Sangryeol Ryu; Soon Jae Kwon; Sun Chang Kim; Claire Booth; Kim E Nichols; Hun Sik Kim
Journal:  Nat Commun       Date:  2016-05-25       Impact factor: 14.919

Review 7.  More than Decoration: Roles for Natural Killer Group 2 Member D Ligand Expression by Immune Cells.

Authors:  Andrew P Trembath; Mary A Markiewicz
Journal:  Front Immunol       Date:  2018-02-12       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.